Inactivator of the third component of complement as an inhibitor in the properdin pathway.
about
Genetics of the complement systemControl of the amplification convertase of complement by the plasma protein beta1HRecurrent infections in partial complement factor I deficiency: evaluation of three generations of a Brazilian familyFamilial atypical hemolytic uremic syndrome: a review of its genetic and clinical aspects.Complement regulation in renal disease modelsActivation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.Acute inflammation. A review.Serum-dependent phagocytosis of paraffin oil emulsified with bacterial lipopolysaccharide.Serum-mediated leukemia cell destruction in AKR mice.Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteinsThe role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B StreptococcusProperdin: binding to C3b and stabilization of the C3b-dependent C3 convertaseThe molecular basis of hereditary complement factor I deficiency.Isolation and analysis of the mechanism of action of an inactivator of C4b in normal human serumThe influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation.The opsonic fragment of the third component of human complement (C3).Restoration by purified C3b inactivator of complement-mediated function in vivo in a patient with C3b inactivator deficiency.Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia.Inhibition of complement-derived enzymes.The mechanism of action of the C3b inactivator (conglutinogen-activating factor) on its naturally occurring substrate, the major fragment of the third component of complement (C3b).C3b inactivator deficiency with immune complex manifestations.
P2860
Q24514917-0DFD41B4-B2B5-44BF-8022-5F40809D7698Q24561671-AE8D5102-ADE6-408D-B8BD-9294BACC1727Q28291779-14AB96B0-6703-449A-9742-D71235218845Q33404888-EB2B2E76-0C99-4271-8813-79FB0E3831F6Q33411137-5FBAF7E2-D872-4590-BEDA-544026464084Q35020107-9707E541-A5B1-4B9F-ABCF-988C74BB860FQ36076876-C21C7EB7-A9C3-4F37-B38E-37A84DA96A18Q36272438-C852F8DC-D53A-4632-A14B-3D9676B68E83Q36334974-9FA72C42-9976-48D5-870B-52B820DFC2B6Q36335627-C4C3A2A6-5DCF-4061-BF1B-8E59928B4387Q36343590-D5A7E0EB-21C2-4D85-8684-D500B606791FQ36358434-81A18AF0-9E1E-4304-8567-E0C1AA2D8BEDQ37351993-7805C7C2-FB46-4853-8C63-D45C9F932D7CQ39323582-95A356A2-202A-41F4-A4AD-50769C0B9F2FQ39349484-0BD87B7B-626C-4927-A99F-9C9BFEDEF493Q40317490-053781AF-69AB-4166-9834-2026E4BEB5C5Q40369403-835C0B50-8120-4355-81A8-D06C380881A1Q40373464-D65FA284-B2AD-4586-896B-4E48555B4CE5Q40705906-A2FC3509-2091-4958-8B47-1AF22704D363Q42940222-79C8DC7A-9622-451A-8F75-A375F6473BA1Q44117763-E698F890-E7AE-4EE0-B797-69A76EF87B57
P2860
Inactivator of the third component of complement as an inhibitor in the properdin pathway.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1972
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inactivator of the third compo ...... itor in the properdin pathway.
@en
Inactivator of the third compo ...... itor in the properdin pathway.
@nl
type
label
Inactivator of the third compo ...... itor in the properdin pathway.
@en
Inactivator of the third compo ...... itor in the properdin pathway.
@nl
prefLabel
Inactivator of the third compo ...... itor in the properdin pathway.
@en
Inactivator of the third compo ...... itor in the properdin pathway.
@nl
P2093
P2860
P356
P1476
Inactivator of the third compo ...... itor in the properdin pathway.
@en
P2093
P2860
P304
P356
10.1073/PNAS.69.10.2910
P407
P577
1972-10-01T00:00:00Z